<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Screening by Northern blot for lck expression in 51 patients with diverse <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic diseases</z:e> has shown, for four of them, a 3 to 15-fold increase in the level of lck <z:chebi fb="2" ids="33699">mRNA</z:chebi> when compared with expression in healthy donors </plain></SENT>
<SENT sid="1" pm="."><plain>These patients suffered from diverse <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>: one Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, one T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and two non-Hodgkin B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Specific analysis of the different lck transcripts in these patients by polymerase chain reaction and their relative quantitation demonstrate a significant increase of only the type IB and the type IC lck transcripts arising from the proximal promotor </plain></SENT>
<SENT sid="3" pm="."><plain>Our study shows: (a) a high lck expression may occur in diverse <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic diseases</z:e>, (b) whatever the type of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, this high expression results in a specific increase of the spliced transcripts arising only from the proximal promotor, and (c) in these four patients without any rearrangement or amplification, the high lck expression probably results from the specific activation of the proximal promotor </plain></SENT>
</text></document>